Latest Close
$28.61
News
ADPT
Adaptive Biotechnologies Corpor News
This news view pulls recent coverage and headlines tied to ADPT.
1y Change
$15.25 (+114.15%)
Market Cap
$4.57B
Sector
Healthcare
Industry
Diagnostics & Research
Recommendation
none
Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
GlobeNewswire • Sep 17, 2026
Read articleAdaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire • Sep 1, 2026
Read articleWhat Is Really Moving Tempus AI Stock Right Now?
Trefis • Aug 24, 2026
Read articleAdaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next.
Barchart • Aug 21, 2026
Read articleAdaptive Biotechnologies Insider Sold Shares Worth $3,135,850, According to a Recent SEC Filing
MT Newswires • Aug 20, 2026
Read articleAdaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?
Zacks • Jul 31, 2026
Read article